Biden’s State Of The Union Will Mention Drug Prices, But Not Outline Any New Plans
President’s address to Congress expected to urge action on the provisions in the stalled Build Back Better legislation as part of a call to address inflation – though whether the speech will include the “i-word” remains unclear. PhRMA emphasizes that drug prices are stable.
You may also be interested in...
Advocates for drug pricing reform don’t have much in the way of price increases to complain about at the moment – but they argue that the price hikes they are seeing suggest a growing confidence among manufacturers that the threat of drug pricing reform is subsiding.
The president’s state of the union address comes after a year of mostly disappointing efforts for the administration on COVID and drug pricing.
Pink Sheet Podcast: Finally, A US FDA User Fee Deal, ‘Pandemic Is Over’ Take-Aways, Tpoxx Development Issues
Pink Sheet reporters and editor discuss the impact of the long wait for a user fee deal to be negotiated, how the FDA will interpret President Biden’s statement that the COVID-19 pandemic is over, and concerns with the clinical development of the monkeypox treatment Tpoxx.